4th Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery
Wednesday May 15, 2024
16:00Opening & introduction
Dr Allen ANNIS (AILERON THERAPEUTICS, Cambridge, United States)
Dr Didier ROCHE (EDELRIS, Lyon, France)
Session 1
16:05PL01 - Simplifying Affinity MS: A One-Step Approach
Prof. Ronald QUINN
(GRIFFITH UNIVERSITY, Brisbane, Australia)
16:50PL02 - An Affinity for Automation
Mr Marcel LACHENMANN
(MESTRELAB RESEARCH, Newton, United States)
17:05Break
17:15PL03 - Nanoscale Synthesis of Cyclic Peptide Libraries and AS-MS Screening
Prof. Christian HEINIS
(ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, Switzerland)
17:50PL04 - Versatile Externalized ASMS Platforms Applied in Lead ID
Dr Hans-Peter BIEMANN
(SANOFI US, Cambridge, United States)
18:25Round table discussion & closing remarks
Thursday May 16, 2024
16:00Opening remarks Day 2
Dr Joseph GAULT
(ASTRAZENECA, Cambridge, United Kingdom)
Session 2
16:05PL05 - Integration of Massive Metabolite Profiling Data of Natural Extracts in Bioactivity Screening Campaigns for Bioactive Hits Prediction and Efficient Prioritization
Prof. Jean-Luc WOLFENDER
(UNIVERSITY OF GENEVA, Geneva, Switzerland)
16:40PL06 - EDEN to Take on New Challenges in Drug Discovery
Dr Charlotte HUROT
(EDELRIS, Lyon, France)
17:15Break
17:25PL07 - An E3 Handle and a Chemical Probe for GID4 via ASMS Hit ID
Dr Dafydd OWEN
(PFIZER, Cambridge, United States)
18:00Round table discussion & closing remarks

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys